MedPath
NMPA Approval

Compound Dyclonine Hydrochloride and Monthal Solution

国药准字H33022133

September 3, 2024

Drug Information

复方达克罗宁薄荷溶液

搽剂

复方

化学药品

September 3, 2024

Company Information

Applicant Company

浙江省兰溪市康恩贝大道1号

Manufacturing Company

浙江省兰溪市康恩贝大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方达克罗宁薄荷溶液 - NMPA 批准文号 | MedPath